Quantification and Profiling of Early and Late Differentiation Stage T Cells in Mantle Cell Lymphoma Reveals Immunotherapeutic Targets in Subsets of Patients

Lavanya Lokhande,Daniel Nilsson,Joana de Matos Rodrigues,May Hassan,Lina M. Olsson,Paul-Theodor Pyl,Louella Vasquez,Anna Porwit,Anna Sandström Gerdtsson,Mats Jerkeman,Sara Ek
DOI: https://doi.org/10.3390/cancers16132289
2024-06-22
Cancers
Abstract:With the aim to advance the understanding of immune regulation in MCL and to identify targetable T-cell subsets, we set out to combine image analysis and spatial omic technology focused on both early and late differentiation stages of T cells. MCL patient tissue (n = 102) was explored using image analysis and GeoMx spatial omics profiling of 69 proteins and 1812 mRNAs. Tumor cells, T helper (TH) cells and cytotoxic (TC) cells of early (CD57−) and late (CD57+) differentiation stage were analyzed. An image analysis workflow was developed based on fine-tuned Cellpose models for cell segmentation and classification. TC and CD57+ subsets of T cells were enriched in tumor-rich compared to tumor-sparse regions. Tumor-sparse regions had a higher expression of several key immune suppressive proteins, tentatively controlling T-cell expansion in regions close to the tumor. We revealed that T cells in late differentiation stages (CD57+) are enriched among MCL infiltrating T cells and are predictive of an increased expression of immune suppressive markers. CD47, IDO1 and CTLA-4 were identified as potential targets for patients with T-cell-rich MCL TIME, while GITR might be a feasible target for MCL patients with sparse T-cell infiltration. In subgroups of patients with a high degree of CD57+ TC-cell infiltration, several immune checkpoint inhibitors, including TIGIT, PD-L1 and LAG3 were increased, emphasizing the immune-suppressive features of this highly differentiated T-cell subset not previously described in MCL.
oncology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is the behavior of T - cells at different differentiation stages and their roles in the tumor microenvironment in Mantle Cell Lymphoma (MCL). Specifically, researchers hope to quantify and depict T - cells at early and late differentiation stages by combining image analysis and spatial omics techniques, in order to reveal immunotherapy targets in subgroups of MCL patients. The main objectives of the paper include: 1. **Understanding the behavior of T - cells in MCL**: Researchers hope to understand the behavior of different types of T - cells (especially those at early and late differentiation stages) in MCL and how they affect tumor growth, progression, and treatment outcomes. 2. **Identifying potential immunotherapy targets**: By analyzing the distribution and molecular characteristics of T - cells in tumor - rich and tumor - sparse areas, researchers hope to identify possible immunotherapy targets, such as CD47, IDO1, and CTLA - 4. 3. **Exploring the relationship between T - cell subsets and immunosuppression**: Researchers have found that T - cells at the late differentiation stage (CD57+) are more common in tumor - rich areas, and these T - cells show higher expression of immunosuppressive markers. This suggests that these T - cells may play an important role in the immunosuppressive mechanism of MCL. 4. **Evaluating the impact of different T - cell infiltration levels on treatment strategies**: Researchers also explored the association between the degree of T - cell infiltration (rich or sparse in T - cells) and the molecular characteristics of tumors and T - cells, thereby providing personalized immunotherapy strategies for different patients. Through these studies, the paper aims to provide new biological insights and potential treatment targets for the immunotherapy of MCL.